CVC occlusion rate per 1000 catheter days Ability to infuse solution through CVC · infants and children with a long‐term CVC
It is very uncertain whether does normal saline flushing in long‐term central venous catheters… changes CVC occlusion rate per 1000 catheter days: ability to infuse… compared with heparin flushing (very low certainty).
1 finding from 1 review
CVC‐associated blood stream infection rate per 1000 catheter days Incidence of positive blood culture · infants and children with a long‐term CVC
Does normal saline flushing in long‐term central venous catheters… showed no clear difference in CVC‐associated blood stream infection rate per 1000 catheter days:… compared with heparin flushing (low certainty).
1 finding from 1 review
Duration of CVC placement (days) · infants and children with a long‐term CVC
1 finding from 1 review
Medium‐ to long‐term complications( · people undergoing elective bifurcated abdominal endovascular aneurysm repair
Totally percutaneous showed no clear difference in medium‐ to long‐term complications( compared with cut‐down femoral artery access (moderate certainty).
1 finding from 1 review
Long‐term all‐cause mortality · people with low‐risk acute pulmonary embolism
Outpatient showed no clear difference in long‐term all‐cause mortality compared with inpatient treatment (low certainty).
1 finding from 1 review
Longer term (> 1 year after disease onset) coronary morbidity (non‐aneurysmal) · children diagnosed with Kawasaki disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recurrent VTE · people requiring treatment for chronic DVT
Chronic DVT ‐ antiplatelet agents plus BMP may leads to lower recurrent VTE ‐ early, intermediate and long term compared with BMP plus placebo (low certainty).
1 finding from 1 review
Mortality ‐ intermediate and long term · people requiring treatment for chronic DVT
Chronic DVT ‐ antiplatelet agents plus BMP showed no clear difference in mortality ‐ intermediate and long term compared with BMP plus placebo (moderate certainty).
1 finding from 1 review
Long‐term recurrence (> 5 years) · people with GSV incompetence
It is very uncertain whether endovenous laser ablation (EVLA) changes long‐term recurrence (> 5 years) compared with ultrasound‐guided foam sclerotherapy (UGFS) (very low certainty).
1 finding from 1 review
Long‐term recurrence (> 5 years) · people with GSV incompetence
Endovenous laser ablation (EVLA) showed no clear difference in long‐term recurrence (> 5 years) compared with SFJ ligation and stripping (HL/S) (moderate certainty).
1 finding from 1 review
Long‐term recurrence (> 5 years) · people with GSV incompetence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Long‐term recurrence (> 5 years) · people with GSV incompetence
Radiofrequency ablation (RFA) may leads to lower long‐term recurrence (> 5 years) compared with SFJ ligation and stripping (HL/S) (low certainty).
1 finding from 1 review
Long‐term recurrence (> 5 years) · people with GSV incompetence
Ultrasound‐guided foam sclerotherapy (UGFS) showed no clear difference in long‐term recurrence (≥ 5 years) compared with SFJ ligation and stripping (HL/S) (low certainty).
1 finding from 1 review
Long‐term recurrence (> 5 years) · people with GSV incompetence
Endovenous laser ablation (EVLA) may leads to higher long‐term recurrence (> 5 years) compared with radiofrequency ablation (RFA) (low certainty).
1 finding from 1 review
Prolonged hospitalization (> 1 week) · patients undergoing surgery with femoral artery approach
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain‐free walking distance · intermittent claudication
1 finding from 1 review
Maximum walking distance · intermittent claudication
1 finding from 1 review
Pain‐free walking distance · intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Maximum walking distance · intermittent claudication
1 finding from 1 review
Pain‐free walking distance · intermittent claudication
1 finding from 1 review